IFF’s 2024 Do More Good Report Highlights Progress in Sustainability and Innovation

25.6.2025 17:00:00 CEST | Business Wire | Press release

The company continues to deliver sustainable solutions that helped customers and consumers avoid 27.3 million metric tons of CO₂e emissions in 2024.

IFF (NYSE: IFF)—a global leader in flavors, fragrances, food ingredients, health, and biosciences—has released its 2024 Do More Good Report which showcases a year of meaningful progress, transformative innovation, and commitment to people and the planet. The report highlights key accomplishments across the organization and emphasizes the impact of IFF’s sustainable solutions through four core pillars, aligned with its new theme, 'The Science of Possible': Conscious Sourcing, Intentional Innovation, Partnerships of Impact, and Operating for the Future.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250625701433/en/

“We’re working to bring the best of science, creativity and heart to everything we do,” said Erik Fyrwald, IFF CEO. “This report is more than a record of progress — it’s a reflection of our commitment to making the impossible possible through sustained innovation.”

This year’s report features a variety of leading innovations that are delivering real value to customers across all the markets served by IFF. One of these is how IFF is working to transition away from fossil-based feedstocks through its family of advanced engineered biomaterials created from the enzymatic polymerization of plant sugar. Designed Enzymatic Biomaterials™ (DEB) technology is an entirely new way to make high-performing, sustainable biomaterials. It represents a breakthrough in product innovation with the potential to replace petrochemical-based products from a wide range of home and personal care markets and industrial applications, in a technically feasible and cost-effective way.

Highlights from the 2024 Do More Good Report include:

Customer-centric sustainability: IFF-enabled products helped avoid 27.3 million metric tons of carbon dioxide equivalent emissions in 2024 — 16.5 times more than the company’s own manufacturing emissions.

Innovation for impact: About 79% of new products launched in 2023–24 included a sustainability value proposition, supporting IFF’s 2030 goal for all new innovations to benefit people and the planet.

Advancing supply chain sustainability: Seventy-five natural ingredients were certified For Life by ECOCERT, supporting conservation and improving farmer livelihoods.

Operational excellence: The company’s safety performance was 40% below 2021 levels, having achieved a 5% reduction in its total recordable incident rate from the prior year. In addition, 100% of employees completed business ethics training.

IFF’s sustainability leadership continues to be recognized by top global benchmarks like Dow Jones Sustainability Index (North America), 2024 EcoVadis Platinum, CDP Climate A List, USA TODAY’s America’s Climate Leaders 2025, and Newsweek’s America’s Most Responsible Companies 2025, among many others.

Explore the full 2024 Do More Good Report.

Cautionary Statement under the Private Securities Litigation Reform Act of 1995

This press release contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements often address expected future business and financial performance and financial condition, and often contain words or phrases such as “plan,” “expect,” “anticipate,” “intend,” “believe,” “seek,” “see,” “will,” “would,” “target,” “potential to,” “working to” or similar expressions, and variations or negatives of these words or phrases. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. The forward-looking statements included in this release are made only as of the date hereof, and we undertake no obligation to update the forward-looking statement to reflect subsequent events or circumstances.

Welcome to IFF

At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience.Learn more at iff.com, LinkedIn, Instagram and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250625701433/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Intelsat Partners with Whitaker Peace & Development Initiative to Expand Access to Education in East Africa25.6.2025 21:00:00 CEST | Press release

Satellite-powered connectivity will support enhanced online education in conflict-affected regions in South Sudan and Uganda Intelsat, operator of one of the world’s largest integrated satellite and terrestrial networks, announced today a groundbreaking partnership with Academy Award-winning actor and humanitarian Forest Whitaker’s nonprofit, the Whitaker Peace & Development Initiative (WPDI), to revolutionize access to education in conflict-affected regions across Africa. The collaboration will deliver for the first time high-speed internet connectivity to WPDI’s Community Learning Centers in South Sudan and Uganda, creating digital bridges to education for thousands of young people in areas where infrastructure has been insufficient or compromised. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250625237871/en/ This unprecedented effort will bring reliable internet access to communities where traditional connectivity infra

Breakthrough in Patient-Derived Stem Cells for Therapeutic Regenerative Medicine25.6.2025 20:00:00 CEST | Press release

Minerva Biotechnologies published, “The Wnt pathway induces a naïve-like subpopulation in primed stem cells, while NME7AB leads to a homogeneous naïve-like population,” in the journal PLOS One, https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0325997 These studies shed light on the scientific controversy of whether activation of the Wnt/β-catenin pathway induces human stem cell pluripotency or differentiation. The literature is replete with contradictory conclusions, based on what appear to be sound scientific studies. Others reported that low levels of β-catenin skew differentiation down neuroectoderm, whereas high levels favor differentiation down mesendoderm. Recently two research groups independently found that “boosting” β-catenin just prior to differentiation improved differentiation of both neuroectoderm and mesendoderm. Unexpectedly, our studies found that, in the absence of other growth factors, activation of the Wnt/β-catenin pathway induced two segregated po

Moody’s fully acquires ICR Chile, solidifying its leading position in key Latin American markets25.6.2025 15:00:00 CEST | Press release

Moody’s Corporation (NYSE:MCO) announced today that it has fully acquired ICR Chile (ICR), a leading provider of domestic credit ratings in Chile. The transaction follows Moody’s 2019 acquisition of a minority stake in ICR and will further strengthen its presence in Latin America’s domestic credit markets. Following the transaction, ICR will continue issuing domestic ratings in Chile under its own rating process and methodologies. In the following months, ICR will be fully integrated into Moody’s Local, a group of leading credit rating agencies in Latin America. “Today’s acquisition builds on our successful partnership with ICR and underscores our commitment to Chile’s growing debt capital market,” said Martin Fernandez-Romero, Managing Director of Moody’s Local. “Bringing ICR into Moody’s Local will enhance our ability to provide high quality credit ratings, research, and analytical services to market participants, while contributing to greater transparency in Latin America.” Founded

Empatica Unveils EmbraceMini: The World’s Smallest Actigraphy Wearable for Clinical Trials25.6.2025 15:00:00 CEST | Press release

Empatica, a pioneer in digital biomarker development and patient monitoring using wearables and AI, today unveiled EmbraceMini, its revolutionary new wearable for clinical trials. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250617320584/en/ EmbraceMini is an ultra-compact health monitoring device, focused on delivering exceptional wearability and high-quality data without compromising sponsor or participant needs. At just 12mm thick and 14mm wide, EmbraceMini is the smallest wristworn actigraphy device for clinical research in the world – the size of a USB flash drive or AA battery. EmbraceMini is an ultra-compact health monitoring device, focused on delivering exceptional wearability and high-quality data without compromising sponsor or participant needs. With its incredibly small footprint and refined looks, EmbraceMini offers effortless, seamless and non-invasive activity data collection while prioritizing the patient

Expensify Expands Global Support for Company Cards, Languages, Billing, and Reimbursements25.6.2025 15:00:00 CEST | Press release

The financial superapp now supports corporate cards from thousands more banks worldwide, alongside a handful of other major international upgrades Expensify, Inc. (Nasdaq: EXFY), the financial management superapp for expenses, travel, and corporate cards, today announced a sweeping expansion of international support across its platform. The launch includes support for corporate card import from 10,000+ more banks worldwide, multilingual capabilities, Euro-based billing, international reimbursements in New Expensify, and beta access to the Expensify Card across the UK, EU, and soon Canada. These updates mark a milestone in Expensify’s global strategy, enabling businesses across the world to manage expenses and cards faster and more seamlessly than ever before—all within a single platform. “Now, companies everywhere can handle expenses, cards, reimbursements, and more — entirely within Expensify,” said David Barrett, founder and CEO of Expensify. Highlights of today’s international expan

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom